CorMedix Inc.
CRMD
$8.13
-$0.05-0.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 280.50% | 384.60% | 617.03% | 1,647.67% | 14,970.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 280.50% | 384.60% | 617.03% | 1,647.67% | 14,970.57% |
| Cost of Revenue | 784.95% | 753.76% | 615.80% | 513.55% | 284.90% |
| Gross Profit | 258.34% | 366.72% | 617.13% | 1,863.81% | 22,384.81% |
| SG&A Expenses | 117.51% | 100.92% | 63.68% | 44.72% | 14.81% |
| Depreciation & Amortization | 16,423.13% | 15,361.60% | 13,238.56% | 7,192.10% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 225.65% | 188.16% | 129.94% | 74.54% | 22.42% |
| Operating Income | 360.76% | 1,308.62% | 817.22% | 303.98% | 184.82% |
| Income Before Tax | 293.57% | 976.94% | 876.28% | 325.13% | 194.81% |
| Income Tax Expenses | 3,010.10% | 2,002,850.00% | -834.66% | -3,876.56% | 137.41% |
| Earnings from Continuing Operations | 265.86% | 953.61% | 1,009.40% | 452.12% | 196.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 265.86% | 953.61% | 1,009.40% | 452.12% | 196.32% |
| EBIT | 360.76% | 1,308.62% | 817.22% | 303.98% | 184.82% |
| EBITDA | 426.63% | 1,433.20% | 893.30% | 313.13% | 185.95% |
| EPS Basic | 209.62% | 877.65% | 776.41% | 381.38% | 184.00% |
| Normalized Basic EPS | 267.56% | 991.95% | 719.81% | 283.86% | 182.84% |
| EPS Diluted | 187.34% | 868.98% | 698.95% | 354.06% | 179.98% |
| Normalized Diluted EPS | 228.40% | 918.24% | 646.98% | 269.89% | 179.29% |
| Average Basic Shares Outstanding | 23.36% | 24.26% | 22.29% | 16.97% | 10.67% |
| Average Diluted Shares Outstanding | 39.95% | 39.73% | 36.34% | 24.76% | 14.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |